Last update 17 Jul 2025

US20230250089

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
MAP4K3
Action
inhibitors
Mechanism
MAP4K3 inhibitors(mitogen-activated protein kinase kinase kinase kinase 3 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesNervous System Diseases+ [4]
Active Indication
ArthritisCeliac DiseaseImmune System Diseases+ [3]
Inactive Indication-
Originator Organization
Arizona Board of RegentsArizona Board of RegentsThe Regents of the University of CaliforniaThe Regents of the University of California
Active Organization
Arizona Board of RegentsArizona Board of RegentsThe Regents of the University of CaliforniaThe Regents of the University of California
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with US20230250089
Login to view more data
100 Translational Medicine associated with US20230250089
Login to view more data
100 Patents (Medical) associated with US20230250089
Login to view more data
100 Deals associated with US20230250089
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ArthritisDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
10 Aug 2023
ArthritisDiscovery-
Arizona Board of RegentsArizona Board of Regents
10 Aug 2023
Celiac DiseaseDiscovery-
Arizona Board of RegentsArizona Board of Regents
10 Aug 2023
Celiac DiseaseDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
10 Aug 2023
Immune System DiseasesDiscovery-
Arizona Board of RegentsArizona Board of Regents
10 Aug 2023
Immune System DiseasesDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
10 Aug 2023
NeoplasmsDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
10 Aug 2023
NeoplasmsDiscovery-
Arizona Board of RegentsArizona Board of Regents
10 Aug 2023
Nervous System DiseasesDiscovery-
Arizona Board of RegentsArizona Board of Regents
10 Aug 2023
Nervous System DiseasesDiscovery-
The Regents of the University of CaliforniaThe Regents of the University of California
10 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free